SL9A3 Polyclonal Antibody

Rabbit Anti-SL9A3 Polyclonal Antibody

Product Specifications

Background

SLC9A3 (Solute Carrier Family 9 Member A3) is a Protein Coding gene. Diseases associated with SLC9A3 include Diarrhea 8, Secretory Sodium, Congenital and Diarrhea 3, Secretory Sodium, Congenital, Syndromic. Among its related pathways are Collagen chain trimerization and Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds. he protein encoded by this gene is an epithelial brush border Na/H exchanger that uses an inward sodium ion gradient to expel acids from the cell. Defects in SLC9A3 are a cause of congenital secretory sodium diarrhea. Pseudogenes of this gene exist on chromosomes 10 and 22.

CAS Number

9007-83-4

Product Name Alternative

Sodium/hydrogen exchanger 3; Na (+) /H (+) exchanger 3; NHE-3; Solute carrier family 9 member 3

Gene ID

6550

Accession Number

P48764

Reactivity

Human, Rat

Immunogen

Synthesized peptide derived from part region of human SL9A3 protein at amino acid sequence of 490-570

Clonality

Polyclonal

Tag

SL9A3

Applications

WB, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

91kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

The antibody detects endogenous levels of SL9A3 protein

Observed Molecular Weight

Formulation

Liquid solution

Buffer pH

PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000; ELISA 1:5000-20000